STOCK TITAN

BBBY (BBBY) director receives RSU grant and vested shares plus prior warrants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bed Bath & Beyond director William Benjamin Nettles Jr. reported compensation-related equity transactions, with no open-market buying or selling. On May 15, 2026, restricted stock units covering 26,873 shares of common stock vested and were delivered, increasing his direct common stock holdings to 49,747 shares.

On May 14, 2026, he received a new grant of 35,181 restricted stock units, each representing a contingent right to one share of common stock that vests at the close of business on May 14, 2027. The filing also notes 2,286 common stock warrants originally issued on October 7, 2025 as a pro‑rata distribution to all common shareholders, each with a $15.50 exercise price.

Positive

  • None.

Negative

  • None.
Insider Nettles William Benjamin JR
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 26,873 $0.00 --
Exercise Common Stock 26,873 $0.00 --
Grant/Award Restricted Stock Units 35,181 $0.00 --
Grant/Award Common Stock Warrant 2,286 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 49,747 shares (Direct, null); Common Stock Warrant — 2,286 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
RSUs vested 26,873 shares Restricted stock units converting into common stock on May 15, 2026
Common shares held 49,747 shares Direct common stock ownership after May 15, 2026 vesting
New RSU grant 35,181 units Restricted stock units granted on May 14, 2026 vesting May 14, 2027
Warrants granted 2,286 warrants Common stock warrants originally issued October 7, 2025
Warrant exercise price $15.50 per warrant Exercise price for each common stock warrant
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Common Stock Warrant financial
"Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock."
A common stock warrant is a tradable right that lets its holder buy a company’s common shares at a fixed price within a set time period. For investors it acts like a long‑dated option: it can magnify gains if the share price rises above the fixed price, but it also creates potential dilution because new shares are issued when warrants are used, which can reduce the value of existing shares.
pro-rata distribution financial
"Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock."
A pro-rata distribution is when cash, shares, rights or other assets are divided among investors in proportion to their ownership stake, so each holder gets the same percentage of the total as their share of the company. Think of slicing a pie so everyone receives pieces sized to match how much of the pie they own. For investors this matters because it preserves relative ownership and determines how much value or new securities they receive, and whether they need to buy or sell to maintain their position.
Section 16 regulatory
"This distribution was exempt from immediate reporting under Section 16."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nettles William Benjamin JR

(Last)(First)(Middle)
433 ASCENSION WAY
3RD FLOOR

(Street)
MURRAY UTAH 84123

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BED BATH & BEYOND, INC. [ BBBY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026M26,873A(1)49,747D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(2)05/14/2026A35,181 (2) (2)Common Stock35,181$035,181(2)D
Restricted Stock Units(1)05/15/2026M26,873 (1) (1)Common Stock26,873$00(1)D
Common Stock Warrant$15.510/07/2025A2,286(3)12/03/202510/07/2026Common Stock2,286$02,286D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
2. Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
3. Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.
/s/ Christina Wheeler, Attorney-in-Fact05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity transactions did BBBY director William Benjamin Nettles Jr. report?

He reported vesting of 26,873 restricted stock units into common shares and a new grant of 35,181 restricted stock units, plus previously issued 2,286 common stock warrants. All entries reflect compensation or pro‑rata distributions, not open-market purchases or sales.

How many Bed Bath & Beyond (BBBY) shares does Nettles hold after these transactions?

After the May 15, 2026 vesting, Nettles directly holds 49,747 shares of Bed Bath & Beyond common stock. This figure reflects shares received from restricted stock units converting into common stock as reported in the Form 4, all shown as direct ownership.

What are the terms of the new restricted stock unit grant reported by BBBY?

The new grant consists of 35,181 restricted stock units, each representing a contingent right to one share of Bed Bath & Beyond common stock. These units vest at the close of business on May 14, 2027, with vested shares delivered promptly after vesting to the reporting person.

What happened to Nettles’ previously granted restricted stock units at BBBY?

Restricted stock units covering 26,873 shares vested at the close of business on May 15, 2026. Upon vesting, an equivalent number of Bed Bath & Beyond common shares were delivered to Nettles, and the related restricted stock unit derivative position was reduced to zero in the reporting tables.

What are the details of the Bed Bath & Beyond warrants reported in this Form 4?

Nettles holds 2,286 common stock warrants originally issued on October 7, 2025, as a pro‑rata distribution to all common shareholders. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant, with Section 16 reporting originally exempt.

Do the reported Bed Bath & Beyond (BBBY) transactions involve open-market buying or selling?

No. The filing shows vesting and delivery of restricted stock units, a new restricted stock unit grant, and previously issued warrants from a pro‑rata distribution. There are no open-market purchase or sale transactions; all activity is compensation-related or corporate distributions.